CN Patent

CN102743330A — 药物组合物

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2012-10-24 · 14y expired

What this patent protects

本发明提供了含有稳定化的药物活性组分的药物组合物或固体制剂和使其稳定的方法。按照本发明，可以通过含有带有伯或仲氨基的非肽药物活性组分、赋形剂和酸性化合物来使药物组合物稳定。另外，含有药物活性组分、二氧化钛、增塑剂和链状有机酸的固体制剂可以在光照期间提高药物活性组分的稳定性。

USPTO Abstract

本发明提供了含有稳定化的药物活性组分的药物组合物或固体制剂和使其稳定的方法。按照本发明，可以通过含有带有伯或仲氨基的非肽药物活性组分、赋形剂和酸性化合物来使药物组合物稳定。另外，含有药物活性组分、二氧化钛、增塑剂和链状有机酸的固体制剂可以在光照期间提高药物活性组分的稳定性。

Drugs covered by this patent

vonoprazan-fumarate (VONOPRAZAN FUMARATE)

Patent Metadata

Patent number: CN102743330A
Jurisdiction: CN
Classification: —
Expires: 2012-10-24
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.